Individual murine B cells express a wide range of Ia densities on the plasma membrane. Here we demonstrate that a dramatic increase in B-cell Ia could be induced by overnight exposure to an uncharacterized lymphokine (LK). Membrane I-A and I-E molecules were both increased after LK treatment, whereas membrane IgM remained unchanged. 
INTRODUCTION
The major histocompatibility gene complex has been found in many species since its original description as a gene locus controlling immunological rejection of transplanted tissues. Over the past decade considerable effort has been directed toward understanding the role of these gene products in immune responses. The I region of the mouse major histocompatibility complex (reviewed in [1] ) encodes the Ia antigens, consisting of two glycoproteins, I-A and I-E, each composed of two peptide subunits. Ia antigens are membrane proteins expressed on some cell types within the immune system, including B cells, macrophages (MO), and dendritic cells, as well as being expressed on some other cell types [2, 3] . Ia on cells of the immune system is thought to enable these cells to interact with T cells, which display receptors for Ia. [8] . Nonadherent cells were removed and the adherent fraction was eluted by warming plates for one hour at 370C, followed by vigorous pipetting. This popuiation was approximately 95 percent B cells as determined by anti-Ig and anti-Ia staining and FACS analysis. LK Treatment ofB Cells Spleen cells or purified B cells were cultured (107/ml) overnight in RPMI 1640 with 10 percent fetal calf serum and 30 percent LK in one ml wells (Costar). In some experiments the purified B cells (5 x 106/ml) were reconstituted with the Ig-coated plate nonadherent cells (5 x 106/ml) prior to LK treatment. Cells were then washed and assayed for I-A, I-E, and IgM expression. To assay their APC function, B cells were similarly cultured (with LK and T cells); following the overnight culture, B cells were purified and assayed for APC function.
Fluorescence-Activated Cell Sorter Analysis
Following the overnight culture with LK, B cells were analyzed for Ia density using the FACS IV system (Becton-Dickinson). Cells were washed in phosphate-buffered saline (PBS) (with 0.02 percent sodium azide) and divided into several staining groups. Cells (3 x 106) were then treated with the following antibodies: (i) anti-I-Ak, monoclonal 10-2-16; (ii) anti-I-Ek, monoclonal 14.4.4; and (iii) anti-IgM, polyclonal rabbit anti-MOPC 104E, purified by affinity to 104E. Cells were incubated with saturating concentrations of antibodies for 30 minutes at 40C, then washed twice in PBS azide, and resuspended in 100 ,l of buffer containing a saturating concentration of FITC-protein A (Pharmacia) or FITC-rabbit anti-mouse IgG2a (Nordic). Following 30 minutes' incubation at 40C, cells were washed, resuspended in one ml PBS azide, then kept on ice, and immediately analyzed on the FACS IV. Twenty thousand cells were analyzed for fluorescence intensity. Antigen Presentation Assay C57B6/6J mice were immunized with keyhole limpet hemacyanin (KLH) (100 ,ug, Calbiochem) emulsified in complete Freund's adjuvant (Difco) subcutaneously at the base of the tail. Seven days later, inguinal lymph nodes were removed and cell suspensions prepared. To deplete APC, cells were treated with anti-I-Ab (clone Y3P, [9] ) followed by rabbit serum complement (Dutchland) at 370C for 30 minutes. Cells were then placed in culture (5 x 105/200 ,l/well) with KLH (20 4g/ml) in RPMI with 0.5 percent fresh syngeneic mouse serum in microtiter wells (Falcon) . APC function of unfractionated spleen cells, B cells, or LK-treated B cells was assessed by treating them with mitomycin C (50 ug/ml, Sigma) for 30 minutes at 370C, washing, and adding (105/well) to APC-depleted cultures of lymph node cells. Proliferation was measured four days later by pulsing with 3H-TdR (1 uCi/well, NEN) followed by harvesting on a MASH apparatus (Microbiological Associates), and counting on a liquid scintillation counter.
RESULTS

LK Stimulates Increased Ia Expression by B Cells
LK regulation of B-cell Ia density was examined using overnight exposure of splenic B cells to LK, followed by quantitation of membrane Ia using FACS analysis. Results are shown in Fig The LK-induced change in Ia density represents a true increase, rather than a protection from Ia loss during culture, since B-cell Ia density did not diminish during culture in the absence of LK, but retained the Ia density profile of freshly isolated B cells (not shown). It is also unlikely that the overnight culture with LK produced high-Ia B cells by either killing low-Ia cells or stimulating proliferation of high-Ia cells, since cell viability remained good after culture and very little proliferation occurs during this period in cultured resting B cells.
We have identified several T cell lines and tumors which produce potent B cell-Ia-inducing supernatants (not shown). Thus, T cells may be the relevant spleen cell subpopulation producing the LK detected in the studies presented here. As yet, we have no further information on the nature of the relevant LK. However, two reports have recently appeared on the subject of LK induction of B cell Ia. Roehm et al. [10] detected this LK activity in the supernatants of a T-cell hybridoma stimulated with concanavalin A. In their study the molecular weight of the Ia-inducing LK roughly corresponded to that of B-cell growth factor, and tests of interleukin-2 (IL-2) and IFN'y (recombinant DNA products) failed to indicate Ia-inducing activity on B cells. How might T cells augment the LK action, as observed in Fig. 2 ? One possibility is that they produce more of the LK, i.e., that we have not used an excess of LK, and that cultured T cells (or T cells activated by the added lymphokines) produce the optimal LK concentration. On the other hand, a T cell may deliver a separate signal, different from the LK, to amplify its effect. In either case, B cells were observed reproducibly to fall into zones I and II, the former requiring both T cells and LK, the latter only LK, to display maximal Ia densities. Although both IA (panel A) and IE (panel B) staining indicated two populations of B cells, we have not yet determined whether the two correspond, i.e., whether B cells with low IA also have low IE and those with high IA also have high IE. 
LK Treatment Induces APC Function in B Cells
What is the functional significance of increased Ta on B cells? Antigen presentation to T cells is known to require recognition of Ta on accessory cells. B cells, although they express Ta, are inefficient APCs. We therefore tested whether LK treatment, which increases Ia, would also improve the APC function of B cells. As shown in Fig. 3 , this proved to be the case. Primed LNC were depleted of IA+ cells, resulting in an inhibition of their ability to proliferate when challenged with antigen; various populations of mitomycin-C-treated cells were then tested for the ability to reconstitute proliferation in the APC-depleted LNC. A preparation of unfractionated spleen cells contained APC, as shown, presumably reflecting the dendritic cell or MO content.
On the other hand, normal splenic B cells were unable to reconstitute this response, as shown; even when tenfold more B cells were used (not shown), no reconstitution was observed. LK-treated B cells were, however, quite effective in restoring the response, as shown, indicating an acquisition of APC function by B cells.
Since we have not as yet purified either the IA-inducing or APC-inducing LKs, we do not know whether they are the same entity. function of Ia is thought to be in mediating cellular interactions with T cells [12] , it is reasonable to suppose that the high-Ia B cell is poised for such interaction. The ensuing discussion will outline some possible advantages enjoyed by the poised B cell. One consequence of an Ia increase on B cells may be acquisition of APC function, which, as we show, occurs concomitantly with the Ia increase; but is APC function a physiologically important property of splenic B cells, given the well-established observation that other cells (e.g., dendritic cells [13] We must not assume that the observed increase in B-cell Ia represents the sine qua non of APC function. The resting B cell already displays a significant density of Ia-a higher density, in fact, than most MO's in a population capable of APC function. Thus, the observed Ia increase may be coordinated with, but not in itself constitute, the critical characteristic of the antigen-presenting B cell. Another APC function which could arise following LK treatment is the ability to produce IL-1; this product may perform an essential role in APC function [16, 17] . Indeed, it has recently been demonstrated that human B cells can be induced to secrete IL-I-like molecules [18] .
Moreover, IL-I production by MO is controlled by Ia molecules on the cell membrane;
these Ia molecules may perform a receptor-like role in receiving T-cell stimuli [ 17, 19] . Hence, by increasing its Ia, a B cell may become more sensitive to T-cell stimuli, resulting in IL-I production; alternatively, increased Ia production may be coordinated with competence for IL-I production. Another APC function which may be lacking in normal B cells could be the ability to process antigens adequately; in the case of protein antigens, this processing may generally involve uptake and proteolytic cleavage, followed by membrane display [20] . Additionally, APC function may involve cell surface molecules (as yet unknown) required for interaction with T-cell membranes. Hence, LK treatment could stimulate, in addition to an Ia increase, any number of properties in B cells, rendering them competent to present antigens; we are currently evaluating several of these potential properties.
Thus far, we have discussed the poised B cell from the point of view of its action on T cells, i.e., APC function. However, the LK-treated B cell, in addition to promoting T-cell immunity as an APC, may also derive selfish benefits. Such poised B cells displaying heightened Ia may have an improved likelihood of contact with helper T cells. Consistent with this notion, it has been previously observed that B cells with high la require fewer helper T cells to activate them than do low-Ia B cells [21] . Moreover, we could speculate that a poised B cell with APC function would insure that it is helped by any T cell it encounters (eliminating the need for a third cell type to present antigen) so long as the antigen required for that particular helper T cell is also present. Hence, the poised B cell could activate its own helper T cell, then subsequently, while in the same intimate contact, receive further helper stimuli, driving the B cell to replicate and secrete immunoglobulin.
DEDICATION
As scientist, physician, and scholar, Elisha Atkins is our exemplar. But above all, he inspires us as scientists, by infusing us with an awe and love of nature. For us he has drawn the relationship of the scientist to the natural world as a metaphysical contest pitted between man and his greatest intellectual adversary, the plan of nature. In trying times when petty affairs would break us, it is this romantic view of our profession that will restore us, and that we would hope to transmit in some fractional part to our students after us. It is for this contagious passion that we are most indebted to Elisha Atkins.
